Stay updated on Biosimilar Ustekinumab vs Stelara Clinical Trial

Sign up to get notified when there's something new on the Biosimilar Ustekinumab vs Stelara Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biosimilar Ustekinumab vs Stelara Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now shows revision v3.8.1 instead of v3.8.0; the study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-11-19T17:37:14.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now presents the completed Phase 3 study of biosimilar ustekinumab versus Stelara for moderate-to-severe plaque psoriasis, including its eligibility criteria, locations, treatment arms, outcome measures, and publication details.
    Difference
    49%
    Check dated 2026-11-12T17:24:22.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-29T17:12:14.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A site-wide notice announces that NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during a terminology transition.
    Difference
    1%
    Check dated 2026-10-22T22:44:58.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s site revision label advanced from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-15T21:49:07.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The site footer revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-08T21:50:47.000Z thumbnail image

Stay in the know with updates to Biosimilar Ustekinumab vs Stelara Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biosimilar Ustekinumab vs Stelara Clinical Trial page.